BiotechTube

Zonisamide + Placebo

Phase 3Completed
2 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Epilepsy; Paediatric Partial Onset Seizures

Conditions

Epilepsy; Paediatric Partial Onset Seizures

Trial Timeline

Dec 1, 2008 → Mar 1, 2011

NCT ID
NCT00566254

About Zonisamide + Placebo

Zonisamide + Placebo is a phase 3 stage product being developed by Eisai for Epilepsy; Paediatric Partial Onset Seizures. The current trial status is completed. This product is registered under clinical trial identifier NCT00566254. Target conditions include Epilepsy; Paediatric Partial Onset Seizures.

What happened to similar drugs?

20 of 20 similar drugs in Epilepsy; Paediatric Partial Onset Seizures were approved

Approved (20) Terminated (6) Active (0)
✅ZonegranEisaiApproved
✅Perampanel + PlaceboEisaiApproved
✅perampanelEisaiApproved
✅Perampanel Oral TabletEisaiApproved
✅PerampanelEisaiApproved
✅zonisamide low dose group + zonisamide high dose groupEisaiApproved
✅Zonisamide at targeted daily doses of 100-500 mg/day + Placebo administered to match targeted daily doses of 100-500 mg/dayEisaiApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (5)

NCT IDPhaseStatus
NCT01765608Phase 2Completed
NCT00566254Phase 3Completed
NCT00692003Phase 3Terminated
NCT00693017Phase 3Terminated
NCT00327717Phase 3Completed

Competing Products

20 competing products in Epilepsy; Paediatric Partial Onset Seizures

See all competitors
ProductCompanyStageHype Score
perampanelEisaiPhase 2
35
LacosamideUCBPhase 3
40
Zonisamide + PlaceboEisaiPhase 3
32
ZonegranEisaiApproved
35
perampanel + perampanelEisaiPhase 1
29
Perampanel + PlaceboEisaiApproved
35
perampanelEisaiApproved
35
E2007 + PlaceboEisaiPhase 2
35
Placebo + RufinamideEisaiPhase 3
40
E2007 (perampanel) + PlaceboEisaiPhase 2
35
Perampanel Oral TabletEisaiApproved
43
perampanelEisaiPhase 3
40
PerampanelEisaiPre-clinical
26
Zonisamide + CarbamazepineEisaiPhase 3
40
PerampanelEisaiApproved
43
Perampanel and Microgynon-30 + Perampanel and Microgynon-30EisaiPhase 1
29
PerampanelEisaiPhase 2
35
zonisamide low dose group + zonisamide high dose groupEisaiApproved
43
E2007 + E2007 + PlaceboEisaiPhase 2
35
Zonisamide at targeted daily doses of 100-500 mg/day + Placebo administered to match targeted daily doses of 100-500 mg/dayEisaiApproved
35